Sanofi (Sanofi) Other Current Payables : $0 Mil (As of Jun. 2023)

View and export this data going back to 2002. Start your Free Trial

What is Sanofi Other Current Payables?

Sanofi's Other Current Payables for the quarter that ended in Jun. 2023 was $0 Mil.

Sanofi's quarterly Other Current Payables increased from Jun. 2022 ($-0 Mil) to Dec. 2022 ($756 Mil) but then declined from Dec. 2022 ($756 Mil) to Jun. 2023 ($0 Mil).

Sanofi's annual Other Current Payables increased from Dec. 2021 ($632 Mil) to Dec. 2022 ($756 Mil) and increased from Dec. 2022 ($756 Mil) to Dec. 2023 ($1,031 Mil).

Sanofi Other Current Payables Historical Data

The historical data trend for Sanofi's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sanofi Other Current Payables Chart

Sanofi Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Payables

Get a 7-Day Free Trial

458.89

680.05

631.64

756.36

1,030.54

Sanofi Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Current Payables	Get a 7-Day Free Trial															631.64	-	756.36	-	1,030.54

Sanofi Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Sanofi Other Current Payables Related Terms

Thank you for viewing the detailed overview of Sanofi's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.

Sanofi (Sanofi) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanofi SA (NAS:SNY) » Definitions » Other Current Payables

Comparable Companies

Traded in Other Exchanges

SNYNF:USA SNY:Mexico SANF:Italy 0A2V:UK SANp:UK 0O59:UK SAN:France SNW:Germany SNW2:Germany SNW:Germany SNW:Germany SNW2:Germany SNW:Germany SANO:Austria

Address

46, avenue de la Grande Armée, Paris, FRA, 75017

Website

https://www.sanofi.com

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 15% of total sales, but profits are shared with Regeneron. About 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.